Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Treatment Technologies & Insights
AddedFeb 16, 2024
UpdatedJun 18, 2026
Treatment Technologies & Insights

Treatment Technologies & Insights

Pre-Seed

Health-tech firm creating AI-powered apps to enhance chronic disease patient outcomes.

HQ
Manhattan Beach, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Treatment Technologies & Insights (TTI) is a health-tech firm dedicated to enhancing the health outcomes of chronic disease patients through innovative digital solutions. Founded with a mission to transform healthcare by leveraging patient-reported outcomes (PROs) and artificial intelligence, TTI offers two primary products: chemoWave and Wave Health. These AI-powered apps are designed to assist patients in managing their health by providing personalized insights and tracking tools. TTI focuses on the chronic disease market, particularly oncology, to empower patients and healthcare providers with actionable data.

Notable achievements include a systematic review by Cedars-Sinai, which rated TTI's Wave Health as the top mobile app for tracking patient-reported outcomes in oncology. The company's ecosystem comprises an ePRO solution, a healthcare provider portal, and an AI-driven data analytics engine, which together enhance patient care and clinical decision-making. TTI's impact is evident in its ability to collect diverse real-world data, improving patient outcomes and advancing the field of digital health.

Treatment Technologies & Insights - Similar Companies

Outcomes4Me logo

Outcomes4Me

TreatmentX logo

TreatmentX

treatmentx.com

OutcomeMD logo

OutcomeMD

outcomemd.com

Trellis Health logo

Trellis Health

Caregivers Insight logo

Caregivers Insight

PatientIQ logo

PatientIQ

patientiq.io

TachyHealth logo

TachyHealth

Leal Health logo

Leal Health

leal.health

Trayt logo

Trayt

trayt.health

Patient Premier logo

Patient Premier

patientpremier.com

TransformativeMed logo

TransformativeMed

Outcome Health logo

Outcome Health

HealthTechApps logo

HealthTechApps

healthtechapps.com

MicroHealth logo

MicroHealth

microhealth.com

RxApps logo

RxApps

Treatment Technologies & Insights - Quick Facts

Who are Treatment Technologies & Insights' competitors?

Companies similar to Treatment Technologies & Insights include Outcomes4Me, TreatmentX, OutcomeMD and Trellis Health.

When was Treatment Technologies & Insights founded?

Treatment Technologies & Insights was founded in 2016.

Where is Treatment Technologies & Insights' headquarters located?

Treatment Technologies & Insights' headquarters is located in Manhattan Beach, CA, US.

When was Treatment Technologies & Insights' last funding round?

Treatment Technologies & Insights' most recent funding round was for $1.5M (USD) in August 2022.

How much has Treatment Technologies & Insights raised to-date?

As of Aug 31, 2022, Treatment Technologies & Insights has raised a total of $3.1M (USD).

How many employees does Treatment Technologies & Insights have?

Treatment Technologies & Insights has 18 employees as of Feb 5, 2024.

Treatment Technologies & Insights - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Apps
  • HealthTech
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software